{
    "id": 2736,
    "fullName": "EGFR P699L",
    "impact": "missense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "EGFR P699L lies within a region of the Egfr protein that is important for dimerization, phosphorylation, and activation (UniProt.org). P699L is predicted to confer a loss of function on the Egfr protein as demonstrated by decreased transformation ability as compared to wild-type Egfr in two different cell lines in one study (PMID: 29533785), and is associated with resistance to Egfr inhibitors (PMID: 22722798).",
            "references": [
                {
                    "id": 9192,
                    "pubMedId": 22722798,
                    "title": "Rare and novel epidermal growth factor receptor mutations in non-small-cell lung cancer and lack of clinical response to gefitinib in two cases.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22722798"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 11238,
                    "pubMedId": 29533785,
                    "title": "Systematic Functional Annotation of Somatic Mutations in Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29533785"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "P699L",
    "createDate": "12/12/2014",
    "updateDate": "09/11/2018",
    "referenceTranscriptCoordinates": {
        "id": 135804,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55173955C>T",
        "cDna": "c.2096C>T",
        "protein": "p.P699L",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 17659,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, Tarceva (erlotinib) treatment resulted in massive disease progression in a patient with non-small cell lung cancer harboring EGFR P699L (PMID: 31175009).",
            "molecularProfile": {
                "id": 2558,
                "profileName": "EGFR P699L"
            },
            "therapy": {
                "id": 4,
                "therapyName": "Erlotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 15702,
                    "pubMedId": 31175009,
                    "title": "Clinical Impact of Rare and Compound Mutations of Epidermal Growth Factor Receptor in Patients With Non-Small-Cell Lung Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31175009"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15008,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, Iressa (gefitinib) treatment resulted in rapid disease progression in a patient with lung adenocarcinoma harboring EGFR E804G and P699L (PMID: 22722798).",
            "molecularProfile": {
                "id": 30537,
                "profileName": "EGFR P699L EGFR E804G"
            },
            "therapy": {
                "id": 751,
                "therapyName": "Gefitinib",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 9192,
                    "pubMedId": 22722798,
                    "title": "Rare and novel epidermal growth factor receptor mutations in non-small-cell lung cancer and lack of clinical response to gefitinib in two cases.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22722798"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2558,
            "profileName": "EGFR P699L",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 30537,
            "profileName": "EGFR P699L EGFR E804G",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 135804,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55173955C>T",
            "cDna": "c.2096C>T",
            "protein": "p.P699L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}